Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:2809-2814
doi: 10.1161/hc4701.099786
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Digilio, M. C.
Right arrow Articles by Marino, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Digilio, M. C.
Right arrow Articles by Marino, B.
Related Collections
Right arrow Clinical genetics
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrow Cardiac development
Right arrow Epidemiology

(Circulation. 2001;104:2809.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Complete Transposition of the Great Arteries

Patterns of Congenital Heart Disease in Familial Precurrence

Maria Cristina Digilio, MD; Brett Casey, MD; Alessandra Toscano, MD; Raffaele Calabrò, MD; Giuseppe Pacileo, MD; Maurizio Marasini, MD; Elena Banaudi, MD; Aldo Giannotti, MD; Bruno Dallapiccola, MD; Bruno Marino, MD

From the Departments of Medical Genetics and Pediatric Cardiology, Bambino Gesù Hospital, Rome (M.C.D., A.T., A.G.); the Department of Pathology, Baylor College of Medicine and Texas Children’s Hospital, Houston (B.C.); the Department of Pediatric Cardiology, Monaldi Hospital, Napoli, Italy (R.C., G.P.); the Department of Pediatric Cardiology, G. Gaslini Hospital, Genova, Italy (M.M.); the Department of Pediatric Cardiology, Regina Margherita Hospital, Torino, Italy (E.B.); the Department of Medical Genetics, La Sapienza University and Mendel-CSS Institute, Rome, Italy (B.D.); and the Division of Pediatric Cardiology, Department of Pediatrics, La Sapienza University, Rome, Italy (B.M.).

Correspondence to B. Marino, Cardiologia Pediatrica, Istituto di Pediatria, Università La Sapienza, Viale Regina Elena 324, 00161, Roma, Italia. E-mail bruno.marino{at}uniroma1.it


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Background— Transposition of the great arteries (TGA) is considered to be associated only rarely with genetic syndromes and to have a low risk of precurrence among relatives of affected patients. Because most family studies have involved a relatively small number of patients and evaluated all types of TGA as a single group, we performed a large, prospective study investigating the precurrence of congenital heart disease in families of children with complete, nonsyndromic TGA.

Methods and Results— From January 1997 through December 2000, 370 patients with nonsyndromic, complete TGA were consecutively evaluated and enrolled in the study. The occurrence of cardiac and noncardiac anomalies among relatives of the probands was investigated. Relatives with congenital heart disease were found in 37 of 370 families (10%), including 5 of 37 families (13.5%) with more than one affected relative. TGA itself was the most common precurrent malformation: complete TGA occurred in 6 families and congenitally corrected TGA occurred in 5 families. Precurrence risks for congenital heart disease were calculated at 1.8% (8 of 436) for siblings, 0.5% (4 of 740) for parents, 0.5% (16 of 3261) for first cousins, 0.2% (4 of 2101) for uncles/aunts, and 0.06% (1 of 1480) for grandparents.

Conclusions— The present study shows that TGA is not always sporadic in families. Precurrence of concordant cardiac defects within affected family members supports monogenic or oligogenic inheritance of TGA in certain kindreds. Moreover, the occurrence of complete TGA and congenitally corrected TGA among first-degree relatives in several different families strongly suggests an underlying pathogenetic link between these 2 malformations that has been previously unrecognized.


Key Words: heart defects, congenital • transposition of great vessels • genetics


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Transposition of the great arteries (TGA) accounts for 5% to 7% of all congenital heart defects (CHDs),13 with a prevalence rate of 0.2 per 1000 live births.4 TGA is the most frequent cyanotic CHD5 and the most frequent CHD diagnosed in the neonatal period.1

The genetic contribution to the pathogenesis of TGA is not considered to be strong given that very few familial cases have been described6,7 and that genetic syndromes or extracardiac malformations are uncommonly associated with TGA.1,8 Currently, the mean precurrence risk for CHD among siblings of patients affected with any type of TGA is considered to be 1.4%,7,917 and a recent large population study failed to identify any familial precurrence among 20 offspring of adult patients with TGA.16

Information about precurrence risks among different subgroups of TGA have been provided in only one study,17 which reported that patients with complete TGA (ie, situs solitus, D-loop ventricle, and TGA with or without a ventricular septal defect [VSD]) have the lowest precurrence rate of CHD among siblings (0.27%), whereas a precurrence risk of 2% has been calculated for siblings of patients with complex TGA (with or without a single ventricle, tricuspid atresia, or double outlet right ventricle) or with TGA with the asplenia syndrome/right isomerism form of heterotaxy. Correspondingly, the results of the Baltimore-Washington Infant Study8 showed that complete TGA also has a lower percentage of associated extracardiac defects in comparison with complex TGA.

Anecdotal clinical experience suggested that the occurrence of familial CHD among index cases of TGA might be higher than previously reported, particularly among the subgroup of patients with complete TGA. This study was designed specifically to investigate this hypothesis and to determine whether any particular CHD occurred more commonly than others among relatives of index cases.

Considering that most previous familial studies have involved a relatively small number of patients and evaluated all types of TGA as a single group, we performed a prospective investigation of familial precurrence of CHD in families of children with complete TGA evaluated in 5 Italian departments of pediatric cardiology over 4 years. The study was designed to verify if the familial analysis of a large series of patients could help in the identification of pedigrees at high risk for CHD and to study the types of CHD occurring in relatives of patients with complete TGA.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
From January 1997 to December 2000, 370 consecutive patients with nonsyndromic, complete TGA were evaluated and enrolled in this Italian multicenter study, which was coordinated by the Bambino Gesù Hospital in Rome. Five pediatric cardiology institutions participated to this study: the Bambino Gesù Hospital in Rome (179 patients), the Gaslini Hospital in Genova (87 patients), the Monaldi Hospital in Naples (67 patients), the Regina Margherita Hospital in Torino (23 patients), and the La Sapienza University in Rome (14 patients). There were 260 male (70.3%) and 110 female (29.7%) patients. Mean age was 5.95±4.62 years (range, newborn to 17.7 years). The majority of the patients (347 of 370, 93.8%) were enrolled at the time of a routine postoperative appointment. The remaining patients (23 of 370,6.2%) were enrolled at the time of initial presentation. In all patients, the cardiac diagnosis was confirmed by one or more of the following: echocardiography, cardiac catheterization, surgical intervention, and/or autopsy. The study was restricted to patients with TGA and discordant ventriculoarterial connections (patent semilunar valves), with or without a VSD and/or outflow tract obstructions. All had situs solitus of the atria, levocardia, D-loop of the ventricle, and concordant atrioventricular connections (patent atrioventricular valves). Patients with any type of single ventricle and/or classic findings of heterotaxy (41 patients) were excluded.

Clinical and phenotypical evaluations were performed in all patients by a geneticist to detect extracardiac anomalies. The definition of nonsyndromic was based on an examination at the time of the enrollment in the study. Standard karyotype on peripheral lymphocytes and fluorescent in situ hybridization with Sc11.1 probe for 22q11.2 microdeletion were performed in all cases. Patients with major extracardiac malformations and/or with facial dysmorphisms in the setting of chromosome anomalies, mendelian syndromes, or associations (28 patients) and one patient with a 22q11.2 microdeletion were excluded.

Information about family history was obtained by an interview with the parents of the index cases. The precurrence of cardiac and noncardiac congenital anomalies in relatives of the probands was investigated. Family pedigrees were constructed to include siblings, parents, grandparents, aunts/uncles, and first cousins. Information about more distant relatives was volunteered by some families. The study was approved by our ethics committee. All living first-degree relatives underwent clinical and electrocardiographic examination. In families in which CHD occurred in more than one member, a complete echocardiographic study was performed on all living first- and second-degree relatives.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
TGA with intact ventricular septum (IVS) was diagnosed in 246 of 370 cases (66.5%), and TGA with a VSD was diagnosed in 124 of the 370 cases (33.5%). Of the 246 patients with TGA and IVS, 184 (74.8%) were male and 62 (25.2%) were female; in the 124 patients with TGA and VSD, there were 76 (61.3%) males and 48 (38.7%) females. The difference in sex distribution between the 2 groups (TGA with IVS and TGA with VSD), using {chi}2 analysis (with P<0.05 accepted as significant), is statistically significant (P=0.01).

One or more relatives with CHD were found in 37 of the 370 families (10%). In particular, familial precurrence of CHD was detected in 22 of 246 families (8.9%) of probands with TGA and IVS and in 15 of 124 families (12.1%) of probands with TGA and VSD (P=0.441). The affected relatives had complete TGA in 6 families (Figure 1) and congenitally corrected TGA (situs solitus, L-loop ventricle with discordant atrioventricular connections, and TGA with discordant ventriculoarterial connections) in 5 families (Figure 2). Different types of CHD were also found among relatives of 2 of the families included in Figure 1. In the remaining 26 families, the affected relatives had CHDs different from TGA (Table 1). Some pedigrees with familial aggregation of TGA included in the present study were also previously reported.18,19 Precurrence risks for CHD among relatives in our series of patients with TGA are shown in Table 2. Considering the occurrence of CHD in first-degree relatives of our probands, the heritability of TGA can be estimated as {approx}10% .



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1. Pedigree of 6 families with concordant TGA in affected members. TF indicates tetralogy of Fallot; ASD, atrial septal defect. Arrow indicates propositus; {blacksquare}, male affected; {square}, male unaffected; {bullet}, female affected; {circ}, female unaffected; slashes, deceased.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Pedigree of 5 families of probands with TGA and additional family member with congenitally corrected L-TGA. CCTGA indicates congenitally corrected transposition of the great arteries. For symbols, see Figure 1.


View this table:
[in this window]
[in a new window]
 
Table 1. Cardiac Defects in Relatives of Patients With Complete TGA


View this table:
[in this window]
[in a new window]
 
Table 2. Empirical Risk for Cardiac Defects Obtained in the Present Series of Patients With Complete TGA

Noncardiac anomalies in relatives of the probands were identified in 36 families. The type of noncardiac anomaly is shown in Table 3. The risk rates for noncardiac anomalies in relatives of our probands were 0.7% (3 of 436) for siblings, 0.5% (4 of 740) for parents, 0.8% (26 of 3261) for first cousins, and 0.3% (7 of 2101) for uncles/aunts.


View this table:
[in this window]
[in a new window]
 
Table 3. Noncardiac Anomalies in Relatives of Patients With Complete TGA

Consanguinity was identified in the parents of 5 probands (second cousins in 4 cases and first cousins in one). Eight probands with TGA (6 with TGA and IVS and 2 with TGA and VSD, P=0.89) had an unaffected twin sibling (dizygotic in 5 cases, monozygotic in 3). The ethnicity of the families was Italian in 369 of the 370 families; the ethnicity of the remaining family (pedigree 2 in Figure 1) was Slavic gypsy.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowConclusions
down arrowReferences
 
We analyzed familial precurrence of CHD in a large series of patients with complete TGA from an Italian multicenter study. The results obtained from the investigation of 370 families show a precurrence risk for CHD in siblings of 1.8% (Table 2). Six families with precurrence of concordant TGA (Figure 1) were identified and, surprisingly, in 5 other families, congenitally corrected L-TGA was identified in relatives of index cases (Figure 2).

According to previous literature reports, the mean precurrence rate in siblings of patients with TGA is considered to be 1.4%,7,917 which is just lower than that in our results. In this regard, it is important to consider that most of the studies investigating familial TGA are referring to all types of TGA as a single group. The only exception is the article by Becker et al,17 which showed that the study group of complete TGA (168 patients) had a precurrence rate of only 0.27%. The recent population study published by Burn et al,16 which investigated vertical transmission of TGA, found no cases of CHD among 20 offspring of 104 probands with TGA. In the same study, the precurrence of CHD in siblings of patients with TGA was 0.97% (one case among 103 siblings).

The variety of recurrence risk rates found among different studies may reflect different genetic and geographic backgrounds in populations. The finding of more families with precurrent TGA than previously expected could mean that a study of large numbers of patients may identify pedigrees at high risk for CHD. A combination of chance, decreased penetrance, and nondominant transmission may account for the absence of vertical transmission of CHD found in the study performed by Burn et al.16 Ascertainment bias may also affect the study results, because different anatomic types of TGA allowing survival to adulthood could have a possible different genetic impact in comparison with more severe TGA.

The rate of consanguinity in our series is 1.4% (5 of 370 families). Only few data are available from the literature, but first-cousin matings among parents of patients with TGA have been occasionally reported.20

The higher proportion of male patients affected by TGA reported in previous series1,21,22 was confirmed in our experience. In addition, a statistically significant male preponderance in patients with TGA and IVS in comparison with those with TGA and VSD was also found in our study, similar to the observations reported in the Baltimore-Washington Infant Study.21 The segregation of an X-linked gene could be suspected in families with precurrent TGA in males (Figures 1 and 2), but this type of transmission can be excluded in most of our families because of apparent male-to-male segregation of a putative disease gene (Figures 1 and 2).

Kindreds with familial TGA show that both TGA with VSD and TGA with IVS can occur in the same family. No significant difference was found in precurrence risk rates in families of patients with TGA and IVS in comparison with those of patients with TGA and VSD. Discordant CHDs precurring more often in our pedigrees include tetralogy of Fallot and VSD (Table 1); a multifactorial mode of inheritance of predisposition to familial CHD can be hypothesized in these cases.

Some patterns of familial precurrence observed in our study suggest that the recent pathogenetic classification of CHD is not completely adequate to account for all cases of TGA. In fact, according to the pathogenetic classification proposed by Clark,23,24 complete TGA is grouped among conotruncal heart defects due to abnormalities of ectomesenchymal tissue migration, which are frequently associated with chromosomal deletion 22q11.2 in the setting of DiGeorge/velocardiofacial syndrome. Actually, only a few cases of TGA and deletion 22q11.2 have been reported,2527 suggesting that in only a small percentage of cases can TGA be definitively explained on the basis of a defect in neural crest cell migration. An interesting observation in our series is the occurrence of tetralogy of Fallot related to deletion 22q11.2 in a sister of a male proband with TGA without chromosomal abnormalities (Table 1). The occurrence of CHD in siblings with discordant karyotypes supports the existence of additional genetic predisposing factors, which could play a role in the pathogenesis of familial aggregation of CHDs.28

Ferencz et al,21 however, classified TGA with the group of conotruncal anomalies, but separated this malformation from those with "normally related great arteries," ie, tetralogy of Fallot, truncus arteriosus, and interrupted aortic arch. In fact, TGA seems to differ from the other types of conotruncal defects: it presents with a lower percentage of associated extracardiac anomalies,1,8 a lower risk of familial precurrence of CHD,6,7 and a lower prevalence of deletion 22q11.2.2527

According to general consent, congenitally corrected L-TGA is not included in the group of conotruncal defects, but is classified among the situs and looping abnormalities.21,23,24 The presence of congenitally corrected L-TGA in 5 first-degree relatives of our patients with TGA is quite surprising (Figure 2). Aggregation of complete TGA and L-TGA in the same family suggests a possible genetic and causative connection between the 2 defects. Considering the high prevalence of TGA in patients with heterotaxy29 and based on these cases of familial aggregation, the pathogenetic group of situs and loop abnormalities might include at least some cases of complete TGA.

In this regard, it is interesting to note that a relationship between complete TGA and laterality defects is corroborated by molecular studies investigating some new genes. In fact, mice trans-heterozygous for both SMAD2 and nodal mutations can have TGA, which is associated with right pulmonary isomerism in some cases.30 Mutations of the EGF-CFC gene, CRYPTIC, in humans have been found to be associated with heterotaxic phenotypes31 as well as with some cases of complete TGA.32

In addition, a mutation in the ZIC3 gene, an X-linked gene related to sporadic and familial situs abnormalities, has been detected in a family in which affected males have TGA and midline anomalies but no obvious left-right malformations.33 Familial segregation of both laterality defects and isolated TGA has been also recently observed in one family.34 All these data support the hypothesis that TGA could be included within the spectrum of laterality defects in some cases.

Data from animal studies support the suggestion that TGA and situs/looping abnormalities may be related pathogenetically. Although TGA is the most difficult cardiac malformation to reproduce experimentally, a consistent model of TGA was recently obtained by all-trans retinoic acid administration during mouse pregnancy.35,36 In this animal model, TGA could be found in the presence of both D- and L-loops of the ventricles (ie, complete TGA and congenitally corrected TGA),35 and treatment with retinoic acid in mouse embryos also could induce looping anomalies with right isomerism.37 Moreover, complete TGA (ie, with situs solitus and D-loop ventricle) can be present among heart defects of homozygous iv/iv mice presenting with a high prevalence of visceral heterotaxy and lateralization anomalies.38 Animal models, therefore, support a common pathogenetic mechanism involved in causing some cases of complete TGA along with congenitally corrected TGA and other laterality defects. Complete TGA could be considered a less severe manifestation than typically encountered.

Noncardiac heritable disorders in relatives of patients with complete TGA include a great variety of conditions. Previous observations from the literature report a preferential occurrence of heritable blood disorders in parents of children with TGA,1,39 and this association was also noted in one of the families from our series (Table 3). The rarity of TGA and of hemophilia in the population suggests that the co-occurrence of these diseases in a family could be causally related. Also, in our series (Table 3) as in previous epidemiological studies,1 congenital hypothyroidism was found in relatives of patients with TGA.

In the present study, some limitations concerning the methods of ascertainment of the cases can be pointed out. In fact, our study is not a population-based analysis, considering that our series consists of patients with TGA enrolled at time of hospital admission. In addition, the great majority of the patients were collected when seen for a postoperative appointment. This could constitute a bias in data evaluation, particularly considering that TGA has high preoperative and intraoperative mortality.20 An additional limitation could be due to the fact that imaging tests for CHD were performed routinely only in the first degree relatives of the probands, whereas the presence of CHD in more distant relatives was investigated by interview.


*    Conclusions
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*Conclusions
down arrowReferences
 
The present study shows that TGA is not always a sporadic occurrence in families. Familial precurrence of concordant cardiac defects within affected family members supports monogenic or oligogenic inheritance of TGA in selected pedigrees. This observation has practical implications in genetic counseling for TGA. It is remarkable that TGA and congenitally corrected TGA can segregate in the same family due to a probable monogenic transmission supporting a pathogenetic link between some cases of complete TGA and the situs and looping abnormalities.

The complexity of these observations suggests a multigenic origin of TGA, probably with the involvement of multiple or even unrecognized causative and pathogenetic mechanisms. Large families with multiple members affected by CHD are fundamental for the identification of the genes related to the specific malformations using genetic techniques such as linkage analysis and positional cloning. The collection of pedigrees segregating the gene(s) of interest will provide an important aid for the delineation of the human gene map of CHDs.

Received June 14, 2001; revision received September 26, 2001; accepted September 26, 2001.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowConclusions
*References
 
1. Ferencz C, Rubin JD, Loffredo CA, et al. Epidemiology of Congenital Heart Disease: The Baltimore-Washington Infant Study, 1981–1989. Mount Kisco, NY: Futura Publishing Company; 1993.

2. Fyler DC, Buckley LP, Hellenbrand WE, et al. Report of the New England Regional Infant Cardiac Program. Pediatrics. 1980; 65 (suppl): 375–461.[Medline] [Order article via Infotrieve]

3. Samanek M. Congenital heart malformations: prevalence, severity, survival, and quality of life. Cardiol Young. 2000; 10: 179–185.[Medline] [Order article via Infotrieve]

4. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. Am J Epidemiol. 1985; 121: 31–36.[Abstract/Free Full Text]

5. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol. 1999; 20: 411–417.[Medline] [Order article via Infotrieve]

6. Nora JJ, Meyer TC. Familial nature of congenital heart diseases. Pediatrics. 1966; 37: 329–334.[Abstract/Free Full Text]

7. Nora JJ, Berg K, Nora AH. Cardiovascular Diseases: Genetics, Epidemiology and Prevention. New York: Oxford University Press; 1991.

8. Lurie IW, Kappetein AP, Loffredo CA, et al. Non-cardiac malformations in individuals with outflow tract defects of the heart: the Baltimore-Washington Infant Study (1981–1989). Am J Med Genet. 1995; 59: 76–84.[Medline] [Order article via Infotrieve]

9. Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases: the genetic-environmental interaction. Circulation. 1968; 38: 604–617.[Abstract/Free Full Text]

10. Fuhrmann W. A family study in transposition of the great vessels and in tricuspid atresia. Humangenetik. 1968; 6: 148–157.[Medline] [Order article via Infotrieve]

11. Anderson RC. Fetal and infant death, twinning and cardiac malformations of 2000 children with and without congenital heart disease. Am J Cardiol. 1976; 38: 218–224.[Medline] [Order article via Infotrieve]

12. Sanchez-Cascos A. The recurrence risk in congenital heart disease. Eur J Cardiol. 1978; 7: 197–210.[Medline] [Order article via Infotrieve]

13. Nora JJ, Nora AH. The evolution of specific genetic and environmental counseling in congenital heart diseases. Circulation. 1978; 57: 205–213.[Free Full Text]

14. Briard ML, Chauvet ML, Le Merrer M, et al. Etude épidémiologique et génétique de trois cardiopathies congénitales à révélation néonatale. Arch Fr Pediatr. 1984; 41: 313–321.[Medline] [Order article via Infotrieve]

15. Nora JJ, Nora AH. Update on counseling the family with a first-degree relative with a congenital heart defect. Am J Med Genet. 1988; 29: 137–142.[Medline] [Order article via Infotrieve]

16. Burn J, Brennan P, Little J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet. 1998; 351: 311–316.[Medline] [Order article via Infotrieve]

17. Becker TA, Van Amber R, Moller JH, et al. Occurrence of cardiac malformations in relatives of children with transposition of the great arteries. Am J Med Genet. 1996; 66: 28–32.[Medline] [Order article via Infotrieve]

18. Digilio MC, Marino B, Giannotti A, et al. Familial recurrence of transposition of the great arteries and intact ventricular septum. Am J Med Genet. 1997; 73: 93–94.[Medline] [Order article via Infotrieve]

19. Digilio MC, Marino B, Banaudi E, et al. Familial recurrence of transposition of the great arteries. Lancet. 1998; 351: 1661.

20. Becker SM, Al Halees Z, Molina C, Paterson RM. Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet. 2001; 99: 8–13.[Medline] [Order article via Infotrieve]

21. Ferencz C, Loffredo CA, Correa-Villasenor A, et al. Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: the Baltimore-Washington Infant Study, 1981–1989. Armonk, NY: Futura Publishing Company; 1997.

22. Samanek M. Boy:girl ratio in children born with different forms of cardiac malformations: a population-based study. Pediatr Cardiol. 1994; 15: 53–57.[Medline] [Order article via Infotrieve]

23. Clark EB. Mechanisms in the pathogenesis of congenital cardiac malformations.In: Pierpont ME, Moller JH, eds. Genetics of Cardiovascular Disease. Boston: Nijhoff; 1986: 3–11.

24. Clark EB. Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol. 1996; 20: 465–472.[Medline] [Order article via Infotrieve]

25. Melchionda S, Digilio MC, Mingarelli R, et al. Transposition of the great arteries associated with deletion of chromosome 22q11.2. Am J Cardiol. 1995; 75: 95–98.[Medline] [Order article via Infotrieve]

26. Mehraein Y, Wippermann CF, Michel-Behnke I, et al. Microdeletion 22q11.2 in complex cardiovascular malformations. Hum Genet. 1997; 99: 433–442.[Medline] [Order article via Infotrieve]

27. Marble M, Morava E, Lopez R, et al. Report of a new patient with transposition of the great arteries with deletion of 22q11.2. Am J Med Genet. 1998; 78: 317–318.[Medline] [Order article via Infotrieve]

28. Digilio MC, Marino B, Canepa SA, et al. Congenital heart defect in sibs with discordant karyotypes. Am J Med Genet. 1998; 80: 169–172.[Medline] [Order article via Infotrieve]

29. Phoon CK, Neill CA. Asplenia syndrome: insight into embryology through the analysis of cardiac and extracardiac anomalies. Am J Cardiol. 1994; 73: 581–587.[Medline] [Order article via Infotrieve]

30. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature. 1998; 393: 786–790.[Medline] [Order article via Infotrieve]

31. Bamford RN, Roessler E, Burdine RD, et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet. 2000; 26: 365–369.[Medline] [Order article via Infotrieve]

32. Bamford RN, de la Cruz J, Roessler E, et al. Mutations in the EGF-CFC gene, CRYPTIC, cause human left-right axis abnormalities and transposition of the great arteries. Am J Hum Genet. 2000; 67 (suppl 2): 10.Abstract.

33. Mégarbané A, Salem N, Stephan E, et al. X-linked transposition of the great arteries and incomplete penetrance among males with nonsense mutation in ZIC3. Eur J Hum Genet. 2000; 8: 704–708.[Medline] [Order article via Infotrieve]

34. Morelli SH, Young L, Reid B, Ruttenberg H, Bamshad MJ. Clinical analysis of families with heart, midline, and laterality defects. Am J Med Genet. 2001; 101: 388–392.[Medline] [Order article via Infotrieve]

35. Pexieder T, Blanc O, Pelouch V, et al. Late fetal development of retinoic acid-induced transposition of great arteries: morphology, physiology, and biochemistry.In: Clark EB, Markwald RR, Takao A. Developmental Mechanisms of Heart Disease. Armonk, NY: Futura Publishing; 1995: 297–307.

36. Nakajima Y, Morishima M, Yasui H, et al. Molecular mechanisms of complete transposition of the great arteries produced by all-trans retinoic acid in mouse embryo.In: Clark EB, Markwald RR, Takao A, eds. Developmental Mechanisms of Heart Disease. Armonk, NY: Futura Publishing; 1995: 315–317.

37. Yasui H, Morishima M, Nakazawa M, et al. Anomalous looping, atrioventricular cushion dysplasia, and unilateral ventricular hypoplasia in the mouse embryo with right isomerism induced by retinoic acid. Anat Rec. 1998; 250: 210–219.[Medline] [Order article via Infotrieve]

38. Icardo JM, Sanchez de Vega MJ. Spectrum of heart malformations in mice with situs solitus, situs inversus, and associated visceral heterotaxy. Circulation. 1991; 84: 2547–2558.[Abstract/Free Full Text]

39. Ferencz C, Boughmann JA, Neill CA, et al. Congenital cardiovascular malformations: questions on inheritance. J Am Coll Cardiol. 1989; 14: 756–763.[Abstract]




This article has been cited by other articles:


Home page
Journal of Diagnostic Medical SonographyHome page
S. M. Zhivora
Improving Detection of Transposition of the Great Arteries in Routine Obstetric Sonographic Screening
Journal of Diagnostic Medical Sonography, September 1, 2008; 24(5): 279 - 283.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. T.R. Roofthooft, K. A. Bergman, T. W. Waterbolk, T. Ebels, B. Bartelds, and R. M.F. Berger
Persistent Pulmonary Hypertension of the Newborn With Transposition of the Great Arteries
Ann. Thorac. Surg., April 1, 2007; 83(4): 1446 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. F. Corno, M. J. Kocica, and F. Torrent-Guasp
The helical ventricular myocardial band of Torrent-Guasp: potential implications in congenital heart defects
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S61 - S68.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. Drenthen, P. G. Pieper, M. Ploeg, A. A. Voors, J. W. Roos-Hesselink, B. J.M. Mulder, H. W. Vliegen, K. M. Sollie, T. Ebels, D. J. van Veldhuisen, et al.
Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries
Eur. Heart J., December 1, 2005; 26(23): 2588 - 2595.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Muncke, C. Jung, H. Rudiger, H. Ulmer, R. Roeth, A. Hubert, E. Goldmuntz, D. Driscoll, J. Goodship, K. Schon, et al.
Missense Mutations and Gene Interruption in PROSIT240, a Novel TRAP240-Like Gene, in Patients With Congenital Heart Defect (Transposition of the Great Arteries)
Circulation, December 9, 2003; 108(23): 2843 - 2850.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Marino and A. F. Corno
Spiral pattern: universe, normal heart, and complex congenital defects
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1225 - 1226.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. K. Gill, M. Splitt, G. K. Sharland, and J. M. Simpson
Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography
J. Am. Coll. Cardiol., September 3, 2003; 42(5): 923 - 929.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Digilio, M. C.
Right arrow Articles by Marino, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Digilio, M. C.
Right arrow Articles by Marino, B.
Related Collections
Right arrow Clinical genetics
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrow Cardiac development
Right arrow Epidemiology